Pharmacokinetics of Advantage Arrest in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Dental Caries
Interventions
DRUG

Silver Diamine Fluoride

38% aqueous silver diamine fluoride \[Ag(NH3)\]2F, CAS RN 33040-28-7

Trial Locations (1)

94158

University of California San Francisco Clinical and Translational Science Institute, San Francisco

All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

lead

Advantage Silver Dental Arrest, LLC

INDUSTRY

NCT04186663 - Pharmacokinetics of Advantage Arrest in Children | Biotech Hunter | Biotech Hunter